Brief: Cadrenal Therapeutics Inc - Blank Rome Llp Issued Legal Opinion On $3,438,062 Shares - SEC Filing
18/11/2025 21:46
Nov 18 (Reuters) - Cadrenal Therapeutics Inc CVKD.O: CADRENAL THERAPEUTICS INC - BLANK ROME LLP ISSUED LEGAL OPINION ON $3,438,062 SHARES - SEC FILING Further company coverage: CVKD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology